Group a streptococcal vaccines
US6716433B1 · kind B1 · utility
20Cited by
12References
34Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 10, 1998 |
| Grant date | Apr 6, 2004 |
| Priority date | — |
| Expiry date | Sep 10, 2018 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/825
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides immunogenic synthetic fusion polypeptide which stimulates an immune response against a selected pathogen, comprising at least two immunogenic polypeptides from a Group A streptococci of at least 10 amino acids in length which are capable of stimulating an immune response against Group A strepococci, and a peptide C terminal to the immunogenic polypeptide which protects the immunogenicity of the immunogenic portion, wherein the C-terminal peptide is not required to stimulate an immune response against Group A streptococci.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.